< Back to Schedule

Parallel Session: COVID-19 and the Liver

Sunday, November 15
 
5:30 pm
 - 
7:00 pm

Speakers

No items found.

About the Session

Watch this live session to see some the top research in COVID-19 and the Liver. Content will only be aired on this date, at this time. Don't miss it!

  • Acpolis Score Predits Outcome in Patients of Cirrhosis with SARS-COV-2 Infection-Data from On-Going APASL Covid Liver Injury Spectrum (APCOLIS-1) Study
    Presenting Author Ashok Kumar Choudhury
  • Non-Alcoholic Fatty Liver Disease (NAFLD) Associates with Higher Risk of Developing Symptomatic COVID19 Infection- Initial UK Biobank Observations
    Presenting Author Adriana Roca-Fernandez
  • SARS-COV-2 Infection Produces Serum Porphyrin Accumulation, Dyslipidemia and Severe Metabolic Dysregulation
    Presenting Author Nieves Embade
  • Liver Injury in COVID-19 is Associated with Endothelial-Mediated Hypercoagulability Driven by IL-6 Trans-Signaling
    Presenting Author Matthew Mcconnell
  • Abnormal Liver Function Tests on Admission are Associated with Increased Mortality in Hospitalized Patients with COVID-19:Preliminary Results from a  Large Latin American Cohort
    Presenting Author Manuel Mendizabal
  • Acute-on-Chronic Liver Failure Related to COVID-19 Infection is Associated with Increased In-Hospital Mortality
    Presenting Author Sanjaya Satapathy